KYNTRA BIO, INC. (KYNB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

-1.5M 0 1.5M 3M 4.5M Q3 '24: 123K Q4 '24: 3.1M Q1 '25: 2.7M Q2 '25: 1.3M Q3 '25: 1.1M Q4 '25: 1.3M Q1 '26: 3.7M Q2 '26: -1.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

-1.8M -900K 0 900K 1.8M 2.7M Q2 '24: 858K Q3 '24: 48K Q1 '25: 2.5M Q2 '25: 1.3M Q3 '25: 1M Q4 '25: 999K Q1 '26: -368K Q2 '26: -1.5M Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '24: -47.7M Q4 '24: -7.1M Q1 '25: -14.9M Q2 '25: -12.1M Q3 '25: -5.4M Q4 '25: -13.5M Q1 '26: -13.8M Q2 '26: -17.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-70M 0 70M 140M 210M Q3 '24: -17.1M Q4 '24: 18M Q1 '25: 4.6M Q2 '25: -7.6M Q3 '25: 200.6M Q4 '25: -14.2M Q1 '26: -15.2M Q2 '26: 12M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

-1.5M 0 1.5M 3M 4.5M Q2 '24: 140K Q3 '24: -75K Q1 '25: 252K Q2 '25: 85K Q3 '25: -58K Q4 '25: 278K Q1 '26: 4.1M Q2 '26: 2K Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q2 '24: -39.9M Q3 '24: -8.4M Q4 '24: -30.5M Q1 '25: 2.7M Q2 '25: 12.7M Q3 '25: -1.8M Q1 '26: -13.9M Q2 '26: -4M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q2 '24: -39.9M Q3 '24: -8.5M Q4 '24: -30.6M Q1 '25: 2.7M Q2 '25: 12.7M Q3 '25: -1.9M Q1 '26: -13.9M Q2 '26: -4M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '24: 99M Q2 '24: 4M Q3 '24: 4M Q1 '25: 4M Q2 '25: 4M Q3 '25: 4M Q1 '26: 4M Q2 '26: 4M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-20.00 0.00 20.00 40.00 60.00 Q3 '24: -9.04 Q4 '24: -11.89 Q1 '25: -10.41 Q2 '25: -8.40 Q3 '25: 45.46 Q4 '25: 45.37 Q1 '26: 40.46 Q2 '26: 45.30 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.